Minimally invasive therapy for portal hypertension

Problems in General Surgery

Volumn 16, Issue 4, 1999, Pages 28-43

  Darcy, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; DOPPLER ECHOGRAPHY; HUMAN; MINIMALLY INVASIVE SURGERY; MORBIDITY; PHLEBOGRAPHY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; STENT; SURGICAL APPROACH;

EID: 0033406348     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Saxon RR, Keller FS. Technical aspects of accessing the portal vein during the TIPS procedure. J Vasc Interv Radiol 1997;8:733-44.
2. Longo JM, Bilbao JI, Rousseau HP, et al. Color Doppler-US guidance in transjugular placement of intrahepatic portosystemic shunts. Radiology 1992; 184:281-4.
3. Rees CR, Niblett RL, Lee SP, Diamond NG, Crippin JS. Use of carbon dioxide as a contrast medium for transjugular intrahepatic portosystemic shunt procedures. J Vasc Interv Radiol 1994;5:383-6.
4. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding [see comments]. New England Journal of Medicine 1994;330:165-71.
5. Rossi P, Bezzi M, Salvatori FM, et al. Self-expanding stents in transjugular intrahepatic portosystemic shunt: experience with nitinol Strecker stents. European Radiology 1996;6:741-7.
6. Ugolotti U, Larini P, Marcato C, Saccani A, Puccianti F, Pedretti G. Is the tantalum Strecker stent suitable for TIPS creation? Short- and mid-term results in 20 consecutive patients. Cardiovasc Interv Radiol 1997;20: 38-12.
7. Kerlan RK, Jr., LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portosystemic shunts: current status. AJR Am J Roentgenol 1995;164: 1059-66.
8. Coldwell DM, Ring FJ, Rees CR, et al. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension [see comments]. Radiology 1995;196:335-40.
9. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology 1993;187:413-20.
10. Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998;18:73-89.
11. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995;108:1143-1151.
12. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. "Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114:981-7.
13. Conn HO. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology 1993;17; 148-58.
14. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites [published erratum appears in N Engl J Med 1995 Jun 8;332:1587]. N Engl J Med 1995; 332:1192-7.
15. Crenshaw WB, Gordon FD, McEniff NJ, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200: 185-92.
16. Nazarian GK, Bjarnason H, Dietz CA, Jr., et al. Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173-80.
17. Guevara M, Gines P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems [see comments]. Hepatology 1998;28:416-22.
18. Freedman AM, Sanyal AJ, Tisnado J, et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics 1993;13: 1185-210.
19. Patch D, Nikolopoulou V, McCormick A, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998;28:454-60.
20. Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;115:110-5.
21. Brown RS, Jr., Brumage L, Yee HF, Jr., Lake JR, Roberts JP, Somberg KA. Enterococcal bacteremia after transjugular intrahepatic portosystemic shunts (TIPS). Am J Gastro 1998;93:636-9.
22. Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol 1997; 169:1727-31.
23. Somberg KA, Riegler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 1995;90:549-555.
24. Haskal ZJ, Middlebrook MR. Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994;5: 827-9; discussion 829-30.
25. Hauenstein KH, Haag K, Ochs A, Langer M, Rossle M. The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 1995;194:175-9.
26. Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum RA, Redd DC. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995;195:485-8.
27. Kerlan RK, Laberge JM, Baker EL, et al. Successful Reversal Of Hepatic Encephalopathy With Intentional Occlusion Of Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol 1995;6:917-921.
28. LaBerge JM, Ferrell LD, Ring EJ, et al. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1991;2:549-56.
29. Sanyal AJ, Contos MJ, Yager D, Zhu YN, Willey A, Graham MF. Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: characterization of cell phenotype and function. Hepatology 1998;28:22-32.
30. Saxon RS, Ross PL, Mendel-Hartvig J, et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998;207: 683-93.
31. Sterling KM, Darcy MD. Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. AJR Am J Roentgenol 1997;168:239-44.
32. Haskal ZJ, Pentecost MJ, Soulen MC, Shlansky-Goldberg RD, Baum RA, Cope C. Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results. AJR Am J Roentgenol 1994;163: 439-44.
33. Feldstein VA, Patel MD, LaBerge JM. Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and detection of stenoses. Radiology 1996;201:141-7.
34. Haskal ZJ, Carroll JW, Jacobs JE, et al. Sonography Of Transjugular Intrahepatic Portosystemic Shunts - Detection Of Elevated Portosystemic Gradients and Loss Of Shunt Function. J Vasc Interv Radiol 1997;8: 549-556.
35. Owens CA, Bartolone C, Warner DL, et al. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998;114:975-80.
36. Kanterman RY, Darcy MD, Middleton WD, Sterling KM, Teefey SA, Pilgram TK. Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. AJR 1997;168:467-72.
37. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts [comment] [see comments]. Gastroenterology 1997;112:889-98.
38. Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine. Radiology 1995;196:341-7.
39. Haskal ZJ, Davis A, McAllister A, Furth EE. PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology 1997;205:682-8.
40. Saxon RR, Timmermans HA, Uchida BT, et al. Stent-grafts for revision of tips stenoses and occlusions: a clinical pilot study. J Vasc Interv Radiol 1997;8: 539-548.
41. Quinn SF, Sheley RC, Semonsen KG. Creation of a portal vein to inferior vena cava shunt using CT guidance and a covered endovascular stent. AJR Am J Roentgenol 1997;169:1159-60.
42. Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26:1115-22.
43. Cabrera J, Maynar M, Granados R, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996;110:832-9.
44. Cello JP, Ring EJ, Olcott EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial [see comments]. Ann Intern Med 1997;126:858-65.
45. Merli M, Salerno F, Riggio O, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology 1998;27: 48-53.
46. Rossle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043-9.
47. Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial [see comments]. Ann Intern Med 1997;126: 849-57.
48. Sauer P, Theilmann L, Stremmel W, Benz C, Richter GM, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology 1997;113: 1623-31.
49. Kowdley KV. Evaluating TIPS trials: the devil is in the details? Gastroenterology 1998;114:847-9.
50. Granados R, Cabrera J, Maynar M. Transjugular [corrected] intrahepatic portosystemic shunts compared with sclerotherapy [letter; comment] [published erratum appears in Ann Intern Med 1998 Feb 15;128:330]. Ann Intern Med 1998;128:71; discussion 72.
51. Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996;224:378-84; discussion 384-6.
52. Uflacker R, Alves MA, Cantisani GG, Souza HP, Wagner J, Moraes LF. Treatment of portal vein obstruction by percutaneous transhepatic angioplasty. Gastroenterology 1985;88:176-80.
53. Blum U, Haag K, Rossle M, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 1995;195:153-7.
54. Walser EM, NcNees SW, DeLa Pena O, et al. Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Intern Radiol 1998;9:119-27.
55. Zajko AB, Sheng R, Bron K, Reyes J, Nour B, Tzakis A. Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol 1994;5:121-6.
56. Funaki B, Rosenblum JD, Leef JA, Hackworth CA, Szymski GX, Alonso EM. Angioplasty treatment of portal vein stenosis in children with segmental liver transplants: mid-term results. AJR Am J Roentgenol 1997;169:551-4.
57. Haskal ZJ, Naji A. Treatment of portal vein thrombosis after liver transplantation with percutaneous thrombolysis and stent placement [see comments]. J Vasc Interv Radiol 1993;4:789-92.
58. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol 1990; 1:17-22.
59. Vogelzang RL, Reddy SG, Braun MA, Nemcek AA, Jr. Extrahepatic portal venous stenosis: treatment with percutaneous transhepatic stent placement. J Vasc Interv Radiol 1996;7:269-71.
60. Blum U, Rossle M, Haag K, et al. Budd-Chiari Syndrome - Technical, Hemodynamic, and Clinical Results Of Treatment With Transjugular Intrahepatic Portosystemic Shunt. Radiology 1995;197:805-811.
61. Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993;186: 523-7.
62. Henderson JM, El Khishen MA, Millikan WJ, Jr., Sones PJ, Warren WD. Management of stenosis of distal splenorenal shunt by balloon dilation. Surg Gynecol Obstet 1983;157:43-8.
63. Hausegger KA, Klein GE, Fluckiger F, Planinz W, Wildling R, Sternthal HM. Stenosis of a surgical portosystemic shunt-treatment with angioplasty and placement of a Wallstent. Cardiovasc Intervent Radiol 1993;16:243-4.
64. Pulido-Duque JM, Gorriz E, Reyes R, Ferrai H, Maynar M. Transcatheter placement of a metallic stent for treatment of an occluded H-graft portacaval shunt. AJR Am J Roentgenol 1992;159:1227-8.
65. Ruff RJ, Chuang VP, Alspaugh JP, Casarella WJ, Tuten TU, Gaylord GM. Percutaneous vascular intervention after surgical shunting for portal hypertension. Radiology 1987;164:469-74.
66. Soyer P, Levesque M, Zeitoun G. Treatment of mesocaval shunt stenosis with a metallic stent. AJR Am J Roentgenol 1992;158:1251-3.
67. Cope C. Dilatation of mesocaval shunts. Ann Radiol 1986;29:178-80.
68. Coldwell DM, Moore AD, Ben-Menachem Y, Johansen KH. Bleeding gastroesophageal varices: gastric vein embolization after partial portal decompression. Radiology 1991;178:249-51.